Evaluation of the skin irritation using a DNA microarray on a reconstructed human epidermal model

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 2, 2009, Pages 203-208

  Niwa, Makoto ^a   Nagai, Kanji ^b,c   Oike, Hideaki ^b   Kobori, Masuko ^b  

^a Katakura Chikkarin Co Ltd   (Japan)

^b NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Activator protein 1; DNA microarray; Heat shock protein; Irritation; Reconstructed human epidermis; Sodium dodecyl sulfate

Indexed keywords

DNA; DODECYL SULFATE SODIUM; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 1A; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; DIAGNOSTIC VALUE; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MARKER GENE; NONBIOLOGICAL MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; RECONSTRUCTED HUMAN EPIDERMAL MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN IRRITATION;

DNA; EPIDERMIS; GENE EXPRESSION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IRRITANTS; MYELOID DIFFERENTIATION FACTOR 88; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, INTERLEUKIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SKIN; SODIUM DODECYL SULFATE; TETRAZOLIUM SALTS; THIAZOLES; TISSUE CULTURE TECHNIQUES;

EID: 60749105578     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.203     Document Type: Article

References (33)

1. Draize J. H., Woodard G., Calvery H. O., J. Pharmacol. Exp. Ther., 82, 377-390 (1994).
2. Vinardell M. P., Mitjans M., J. Pharm. Sci., 97, 46-59 (2008).
3. European Commission, Official J. European Union, 76/768/EEC (2004).
4. European Commission, EN, SEC (2004) 1210.
5. Based on "Statement on the Validity of in Vitro Tests for Skin Irritation," ESAC, ECVAM, April 27th, 2007.
6. Fletcher S. T., Baker V A., Fentem J. H., Basketter D. A., Kelsell D. P., Toxicol. In Vitro, 15, 393-398 (2001).
7. Borlon C., Godard P., Eskes C., Hartung T., Zuang V, Toussaint O., Toxicology, 241, 157-166 (2007).
8. Kobori M., Nakayama H., Fukushima K., Ohnishi-Kameyama M., Ono H., Fukushima T., Akimoto Y., Masumoto S., Yukizaki C., Hoshi Y., Deguchi T., Yoshida M., J. Agric. Food. Chem., 56, 4004-4011 (2008).
9. Kojima H., Ishii I., Nakata S., Konishi H., Alternatives to Animal Testing and Experimentation, 11, 177-184 (2006).
10. de Brugerolle de Fraissinette, Picarles V., Chibout S., Kolopp M., Medina J., Burtin P., Ebelin M. E., Osborne S., Mayer F. K., Spake A., Rosdy M., De Wever B., Ettlin R. A., Cordier A., Cell. Biol. Toxicol., 15, 121-135 (1999).
11. Poumay Y., Dupont F., Marcoux S., Leclercq-Smekens M., Hérin M., Coquette A., Arch. Dermatol. Res., 296, 203-211 (2004).
12. Coqutte A., Berna N., Vandenbosch A., Rosdy M., Roumay Y., Toxicol. In Vitro, 13, 867-877 (1999).
13. Coquette A., Berna N., Vandenbosch A., Rosdy M., De Wever B., Poumay Y., Toxicol. In Vitro, 17, 311-321 (2003).
14. Gibbs S., Vietsch H., Meier U., Ponec M., Exp. Dermatol., 11, 217-223 (2002).
15. Törmä H., Geijer S., Gester T., Alpholm K., Berne B., Lindberg M., Toxicol. In Vitro, 20, 472-179 (2006).
16. Zepter K, Häffner A, Soohoo L. F., De Luca D., Tang H. P., Fisher P., Chavinson J., Elments C. A., J. Immunol., 159, 6203-6208 (1997).
17. Ye. J., Garg A., Calhoun C., Feingold K. R., Elias P. M., Ghadially R., Exp. Dermatol., 11, 209-216 (2002).
18. Ishida Y., Kondo T., Kimura A., Matsushima K., Mukaida N., J. Immunol., 176, 5598-5606 (2006).
19. Yano S., Banno T., Walsh R., Blumenberg M., J. Cell. Physiol., 214, 1-13 (2008).
20. ECVAM SIVS: Final draft performance standards version 2007-05-25.
21. Based on a lecture presented at the 57th Annual Meeting, Society of Investigative Dermatology, Washington D.C., on 1-5 May, 1996.
22. Gosselet F. P., Magnaldo T., Culerrier R. M., Sarasin A., Ehrhart J. C., Cell. Signal., 19, 731-739 (2007).
23. Csiszar A., Ahmad M., Smith K. E., Labinskyy N, Gao Q., Kaley G., Edwards J. G., Wolin M. S., Ungvari Z., Am. J. Pathol., 168, 629-638 (2006).
24. Fukui N., Ikeda Y., Ohnuki T., Hikita A., Tanaka S., Yamane S., Suzuki R., Sandell L. J., Ochi T., J. Biol. Chem., 281, 27229-27241 (2006).
25. Feng J. Q., Xing L., Zhang J. H., Zhao M., Horn D., Chan J., Boyce B. F., Harris S. E., Mundy G. R., Chen D., J. Biol. Chem., 278, 29130-29135 (2003).
26. Pivarcsi A., Bodai L., Rethi B., Kenderessy-Szabó A., Koreck A., Széll M., Beer Z., Bata-Csörgö Z., Magócsi M., Rajnavölgyi É., Dobozy A., Kemény L., Int. Immunol., 15, 721-730 (2003).
27. Lindquist S., Craig E. A., Annu. Rev. Genet., 22, 631-677 (1988).
28. Boehncke W. H., Dahlke A., Zollner T. M., Sterry W., Arch. Dermatol. Res., 287, 68-71 (1994).
29. Angel P., Szabowski A., Schorpp-Kistner M., Oncogene, 20, 2413-2423 (2001).
30. Mehic D., Bakiri L., Ghannadan M., Wagner E. F., Tschachler E., J. Invest. Dermatol., 124, 212-220 (2005).
31. Karin M., J. Biol. Chem., 270, 16483-16486 (1995).
32. Wisdom R., Exp. Cell. Res., 253, 180-185 (1999).
33. Ozolinš T. R. S., Hales B. F., J. Pharmacol. Exp. Ther., 280, 1085-1093 (1997).